PD-1 derived CA-170 is an oral immune checkpoint inhibitor that exhibits preclinical anti-tumor efficacy
PD-1 衍生的 CA-170 是一种口服免疫检查点抑制剂，具有临床前抗肿瘤功效
期刊:Communications Biology
影响因子:5.2
doi:10.1038/s42003-021-02191-1
Pottayil G Sasikumar, Naremaddepalli S Sudarshan, Srinivas Adurthi, Raghuveer K Ramachandra, Dodderi S Samiulla, Anirudha Lakshminarasimhan, Anuradha Ramanathan, Talapaneni Chandrasekhar, Amit A Dhudashiya, Sumalatha R Talapati, Nagesh Gowda, Sreenivasulareddy Palakolanu, Jiju Mani, Bandi Srinivasra
